CDH1 is a widely known proto oncogene in the occurrence and development of cancer [27], while a relatively new oncogenic determinant MET regulates the occurrence, progression, and malignancy of epithelial carcinomas including lung adenocarcinoma [28]. The gene discussed is MET; the disease is cancer.